←Back to Expert Scholars
Translational Medicine / 转化医学Ki67 & Proliferation
Kevin Kalinsky
MD, MS
🏢Winship Cancer Institute of Emory University🌐USA
Director, Glenn Family Breast Center
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Kevin Kalinsky led the RxPONDER trial defining chemotherapy benefit by recurrence score and menopausal status. His work evaluates Ki67 alongside multigene assays for risk stratification. He currently directs the Glenn Family Breast Center at Winship.
Share:
🧪Research Fields 研究领域
HR-positive breast cancer
RxPONDER trial
Oncotype DX
Adjuvant chemotherapy
Precision oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Kevin Kalinsky 的研究动态
Follow Kevin Kalinsky's research updates
留下邮箱，当我们发布与 Kevin Kalinsky（Winship Cancer Institute of Emory University）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment